Personalis Net Income
| PSNL Stock | USD 8.21 0.18 2.15% |
As of the 15th of February 2026, Personalis holds the Coefficient Of Variation of 6104.74, risk adjusted performance of 0.0219, and Semi Deviation of 5.17. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Personalis, as well as the relationship between them. Please check Personalis information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Personalis is priced some-what accurately, providing market reflects its current price of 8.21 per share. Given that Personalis has jensen alpha of (0.10), we recommend you to check out Personalis's recent market performance to make sure the company can sustain itself at a future point.
Personalis Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 8.9599 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -73.2 M | -76.8 M | |
| Net Loss | -102 M | -96.9 M | |
| Net Loss | -73.2 M | -76.8 M | |
| Net Loss | (1.58) | (1.66) | |
| Net Income Per E B T | 0.90 | 0.80 |
Personalis | Net Income | Build AI portfolio with Personalis Stock |
Historical Net Income data for Personalis serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Personalis represents a compelling investment opportunity.
Latest Personalis' Net Income Growth Pattern
Below is the plot of the Net Income of Personalis over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Personalis financial statement analysis. It represents the amount of money remaining after all of Personalis operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Personalis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Personalis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (81.28 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Personalis Net Income Regression Statistics
| Arithmetic Mean | (46,654,352) | |
| Coefficient Of Variation | (69.58) | |
| Mean Deviation | 28,019,279 | |
| Median | (23,598,000) | |
| Standard Deviation | 32,464,219 | |
| Sample Variance | 1053.9T | |
| Range | 93.4M | |
| R-Value | (0.79) | |
| Mean Square Error | 428.9T | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | (5,055,966) | |
| Total Sum of Squares | 16862.8T |
Personalis Net Income History
Other Fundumenentals of Personalis
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Personalis Net Income component correlations
Personalis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Personalis is extremely important. It helps to project a fair market value of Personalis Stock properly, considering its historical fundamentals such as Net Income. Since Personalis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Personalis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Personalis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. Anticipated expansion of Personalis directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Personalis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth (0.44) | Return On Assets | Return On Equity |
Understanding Personalis requires distinguishing between market price and book value, where the latter reflects Personalis's accounting equity. The concept of intrinsic value - what Personalis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Personalis' price substantially above or below its fundamental value.
It's important to distinguish between Personalis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Personalis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Personalis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Personalis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Personalis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Personalis.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Personalis on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Personalis or generate 0.0% return on investment in Personalis over 90 days. Personalis is related to or competes with Myriad Genetics, CareDx, Fulgent Genetics, Castle Biosciences, Tyra Biosciences, Rezolute, and Evolent Health. Personalis, Inc. operates as a cancer genomics company worldwide More
Personalis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Personalis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Personalis upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.33 | |||
| Information Ratio | 0.0048 | |||
| Maximum Drawdown | 28.22 | |||
| Value At Risk | (9.67) | |||
| Potential Upside | 12.21 |
Personalis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Personalis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Personalis' standard deviation. In reality, there are many statistical measures that can use Personalis historical prices to predict the future Personalis' volatility.| Risk Adjusted Performance | 0.0219 | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0054 | |||
| Treynor Ratio | 0.0278 |
Personalis February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0219 | |||
| Market Risk Adjusted Performance | 0.0378 | |||
| Mean Deviation | 4.42 | |||
| Semi Deviation | 5.17 | |||
| Downside Deviation | 5.33 | |||
| Coefficient Of Variation | 6104.74 | |||
| Standard Deviation | 6.02 | |||
| Variance | 36.2 | |||
| Information Ratio | 0.0048 | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0054 | |||
| Treynor Ratio | 0.0278 | |||
| Maximum Drawdown | 28.22 | |||
| Value At Risk | (9.67) | |||
| Potential Upside | 12.21 | |||
| Downside Variance | 28.43 | |||
| Semi Variance | 26.71 | |||
| Expected Short fall | (4.80) | |||
| Skewness | 0.7146 | |||
| Kurtosis | 0.9841 |
Personalis Backtested Returns
Personalis appears to be relatively risky, given 3 months investment horizon. Personalis maintains Sharpe Ratio (i.e., Efficiency) of 0.054, which implies the firm had a 0.054 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Personalis, which you can use to evaluate the volatility of the company. Please evaluate Personalis' Semi Deviation of 5.17, risk adjusted performance of 0.0219, and Coefficient Of Variation of 6104.74 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Personalis holds a performance score of 4. The company holds a Beta of 3.19, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Personalis will likely underperform. Please check Personalis' potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Personalis' historical price patterns will revert.
Auto-correlation | 0.37 |
Below average predictability
Personalis has below average predictability. Overlapping area represents the amount of predictability between Personalis time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Personalis price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Personalis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.8 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Personalis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Personalis reported net income of (81.28 Million). This is 123.82% lower than that of the Life Sciences Tools & Services sector and 146.95% lower than that of the Health Care industry. The net income for all United States stocks is 114.24% higher than that of the company.
Personalis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Personalis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Personalis could also be used in its relative valuation, which is a method of valuing Personalis by comparing valuation metrics of similar companies.Personalis is currently under evaluation in net income category among its peers.
Personalis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Personalis from analyzing Personalis' financial statements. These drivers represent accounts that assess Personalis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Personalis' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 626.3M | 90.5M | 101.2M | 342.5M | 393.8M | 574.9M | |
| Enterprise Value | 579.0M | 50.0M | 91.9M | 295.3M | 339.6M | 540.1M |
Personalis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Personalis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Personalis' managers, analysts, and investors.Environmental | Governance | Social |
Personalis Institutional Holders
Institutional Holdings refers to the ownership stake in Personalis that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Personalis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Personalis' value.| Shares | Dimensional Fund Advisors, Inc. | 2025-06-30 | 784.9 K | State Street Corp | 2025-06-30 | 687.6 K | Kennedy Capital Management Inc | 2025-06-30 | 653.4 K | Sumitomo Mitsui Trust Group Inc | 2025-06-30 | 640.4 K | Nuveen, Llc | 2025-06-30 | 635.6 K | Amova Asset Management Americas, Inc | 2025-06-30 | 634.3 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 626.5 K | Renaissance Technologies Corp | 2025-06-30 | 563.2 K | State Treasurer State Of Michigan | 2025-06-30 | 493.8 K | Merck & Co Inc | 2025-06-30 | 14 M | Lightspeed Management Co Llc | 2025-06-30 | 8.2 M |
Personalis Fundamentals
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (1.07) % | ||||
| Operating Margin | (1.61) % | ||||
| Current Valuation | 619.16 M | ||||
| Shares Outstanding | 88.8 M | ||||
| Shares Owned By Insiders | 31.27 % | ||||
| Shares Owned By Institutions | 67.16 % | ||||
| Number Of Shares Shorted | 8.81 M | ||||
| Price To Book | 4.25 X | ||||
| Price To Sales | 10.55 X | ||||
| Revenue | 84.61 M | ||||
| Gross Profit | 18.43 M | ||||
| EBITDA | (70.3 M) | ||||
| Net Income | (81.28 M) | ||||
| Cash And Equivalents | 233.49 M | ||||
| Cash Per Share | 5.09 X | ||||
| Total Debt | 44.25 M | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 6.26 X | ||||
| Book Value Per Share | 1.93 X | ||||
| Cash Flow From Operations | (45.15 M) | ||||
| Short Ratio | 6.83 X | ||||
| Earnings Per Share | (0.83) X | ||||
| Price To Earnings To Growth | 0.09 X | ||||
| Target Price | 11.29 | ||||
| Number Of Employees | 228 | ||||
| Beta | 2.02 | ||||
| Market Capitalization | 729.08 M | ||||
| Total Asset | 270.27 M | ||||
| Retained Earnings | (549.99 M) | ||||
| Working Capital | 171.89 M | ||||
| Net Asset | 270.27 M |
About Personalis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Personalis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Personalis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Personalis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. Anticipated expansion of Personalis directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Personalis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth (0.44) | Return On Assets | Return On Equity |
Understanding Personalis requires distinguishing between market price and book value, where the latter reflects Personalis's accounting equity. The concept of intrinsic value - what Personalis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Personalis' price substantially above or below its fundamental value.
It's important to distinguish between Personalis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Personalis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Personalis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.